Short answer · Medically reviewed summary · Last updated: 2026-05-08
Choroideremia is a rare, X-linked genetic disorder primarily characterized by progressive vision loss. While the clinical term Choroideremia is the internationally accepted standard, it is sometimes historically referred to as progressive tapetochoroidal dystrophy or TCD in older medical literature. Why does Choroideremia have multiple names? The naming of Choroideremia has evolved alongside our understanding of its genetic basis.
Choroideremia is a rare, X-linked genetic disorder primarily characterized by progressive vision loss. While the clinical term Choroideremia is the internationally accepted standard, it is sometimes historically referred to as progressive tapetochoroidal dystrophy or TCD in older medical literature.
The naming of Choroideremia has evolved alongside our understanding of its genetic basis. Historically, the condition was described by the appearance of the retina, leading to terms like "progressive tapetochoroidal dystrophy." Because Choroideremia was once thought to be a form of retinitis pigmentosa, older clinical records may sometimes misclassify it under broader headings. Today, the name Choroideremia is preferred as it specifically describes the degeneration of the choroid and retinal pigment epithelium caused by mutations in the CHM gene.
When searching for information or reviewing medical files, you may encounter several alternative labels. It is important to recognize these variations to ensure you are accessing accurate, peer-reviewed data:
Standardized nomenclature is essential for global research and patient support. In major medical classification systems, Choroideremia is categorized as follows:
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.